Skip to main content

Table 2 Animal studies that investigated the therapeutic effects of resveratrol on anxiety

From: Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence

Disease

Dose of resveratrol

Model

Findings

Publish year

Refs.

PTSD-induced anxiety

10, 20 and 40 mg/kg

In vivo

Alleviate L-HPA axis, corticotrophin-releasing factor levels, and glucocorticoid receptor in the hypothalamus, hippocampus, and amygdala, increased pCREB and BDNF

2018

[108]

PTSD-induced anxiety

40 mg/kg

In vivo

Alleviate L-HPA axis, elevated protein kinase A, phosphorylated CREB protein, and BDNF

2020

[109]

Anxiety

200 and 400 mg/kg

In vivo

Anxiolysis and anti-psychotic effects

2017

[119]

Ovariectomy-induced anxiety

20 mg/kg

In vivo

Decreased anxiety-like behaviors, decreased activation of microglia in the hippocampal dentate gyrus, hippocampal levels of NLRP3, and NF-kB, inhibited cytokine production, increased Sirt1 concentrations

2019

[85]

Diabetes-induced anxiety

10 mg/kg/day

In vivo

Increased Sirt1 and Sirt7

2016

[118]

Anxiety

1 and 2 mg/kg

In vivo

Anxiolytic function

2013

[120]